A medicine packaging box

Abstract

This utility model belongs to the field of pharmaceutical packaging technology, specifically relating to a pharmaceutical packaging box. The utility model includes: a shell; at least two limiting clips disposed inside the shell, the curvature of which is adapted to the body of the vial containing the medicine; a front baffle and a rear baffle, respectively disposed at the front and rear ends of the vial; and a sealing film completely covering the top surface of the shell. This utility model addresses the technical problem that existing single-unit vial packaging boxes cannot provide adequate limiting support and protection.

Description

Technical Field

[0001] This utility model belongs to the field of pharmaceutical packaging technology, specifically relating to a pharmaceutical packaging box. Background Technology

[0002] Targeted therapies used to treat cancer generally include ordinary oral medications (tablets), as well as aqueous solutions or lyophilized powders packaged in vials. Due to their specificity and high research and development costs, targeted therapies have consistently maintained a high value.

[0003] Currently, the packaging used for vials generally includes bulk packaging and individual packaging. Bulk packaging involves placing multiple vials on a mounting plate, and then packaging the mounting plate in a box. Bulk packaging is not suitable for targeted drugs, mainly because targeted drugs have a high unit price, which can easily lead to an excessively high total price and increase procurement pressure. Therefore, individual packaging is more suitable for targeted drug packaging. However, existing individual packaging generally involves punching holes in cardboard and then folding it into a limiting support for the vials. The structural strength of this limiting support is poor and cannot provide good limiting support and protection. Utility Model Content

[0004] This utility model provides a pharmaceutical packaging box to solve the technical problem that the box body of the single-unit packaged vial in the prior art cannot provide good limiting support and protection.

[0005] This utility model includes: a shell;

[0006] At least two limiting clips are provided inside the housing, and the curvature of the limiting clips is adapted to the body of the vial containing the medicine;

[0007] A front baffle and a rear baffle are respectively located at the front end and the rear end of the vial;

[0008] A sealing film completely covers the top surface of the housing.

[0009] This utility model provides a basically complete protective barrier through the shell, limits the position of the vial through the limiting card and the front / rear baffle, and forms a closed cavity through the combination of the sealing film and the shell, which can achieve protection of the vial.

[0010] Furthermore: the limiting card includes two symmetrical claws and a base, the bottom surface of the base is connected to the bottom of the housing, and the top surface of the base is an arc surface adapted to the bottle body;

[0011] The lower parts of the two claws are smoothly connected to both ends of the base. The beneficial effect of this step is that the claws and the base can be combined to stably hold the vial.

[0012] Furthermore, a protective atmosphere is filled between the sealing film and the shell. The beneficial effects of this step are that the protective atmosphere has a single component, which can reduce pollution and maintain positive pressure between the shell and the sealing film, thus playing a certain role in shock absorption.

[0013] Furthermore, the shell is made of polyethylene or polypropylene, and the beneficial effect of this step is that the recyclable material is more environmentally friendly.

[0014] Furthermore: the inner or outer surface of the housing is provided with a light-shielding film, and the sealing film includes an aluminum foil layer. The beneficial effect of this step is that it provides light protection and meets the conditions for drug preservation.

[0015] Furthermore, the housing is equipped with an RFID tag, which has the following advantages: the RFID tag records relevant information about the medicine.

[0016] The beneficial effects of this utility model are:

[0017] 1. The shell and sealing film form a closed space, isolating the external air and providing good protection for the vial, preventing contamination during transportation and storage; when the inside is filled with a protective atmosphere, it can also provide a certain amount of shock absorption energy.

[0018] 2. The limiting clips and front / rear baffles can effectively limit and fix the vial, ensuring that the vial is suspended relative to the shell, and reducing the impact force transmitted to the vial when the shell is impacted. Attached Figure Description

[0019] To more clearly illustrate the specific embodiments of this utility model or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of this utility model. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.

[0020] Figure 1 A schematic diagram of the structure of a medicine packaging box provided by this utility model Figure 1 ;

[0021] Figure 2 A schematic diagram of the structure of a medicine packaging box provided by this utility model Figure 2 ;

[0022] Figure 3 for Figure 2 A bottom view.

[0023] Figure label:

[0024] 1-Shell; 2-Sealing film; 3-Village;

[0025] 11-Limiting clip; 12-Front baffle; 13-Rear baffle;

[0026] 111-Base; 112-Claw. Detailed Implementation

[0027] The embodiments of the present invention will now be described in detail with reference to the accompanying drawings. These embodiments are merely illustrative of the present invention and should not be construed as limiting the scope of protection of the present invention.

[0028] It should be noted that, unless otherwise stated, the technical or scientific terms used in this application shall have the ordinary meaning as understood by one of ordinary skill in the art to which this utility model pertains.

[0029] In the description of this application, it should be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", "axial", "radial", "circumferential", etc., indicating the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, are only for the convenience of describing this utility model and simplifying the description, and are not intended to indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this utility model.

[0030] Furthermore, the terms "first," "second," etc., are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. In the description of this utility model, "a plurality of" means two or more, unless otherwise explicitly defined.

[0031] In this application, unless otherwise expressly specified and limited, the terms "installation," "connection," "joining," and "fixing," etc., should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral part; they can refer to a direct connection or an indirect connection through an intermediate medium; they can refer to the internal communication of two components or the interaction between two components. Those skilled in the art can understand the specific meaning of the above terms in this utility model according to the specific circumstances.

[0032] In this application, unless otherwise expressly specified and limited, "above" or "below" the second feature can mean that the first feature is in direct contact with the second feature, or that the first feature is in indirect contact with the second feature through an intermediate medium. Furthermore, "above," "on top of," and "over" the second feature can mean that the first feature is directly above or diagonally above the second feature, or simply that the first feature is at a higher horizontal level than the second feature. "Below," "below," and "under" the second feature can mean that the first feature is directly below or diagonally below the second feature, or simply that the first feature is at a lower horizontal level than the second feature.

[0033] Implementation of this application, for example Figures 1-3 As shown, this utility model provides a pharmaceutical packaging box.

[0034] This application includes: a housing 1;

[0035] At least two limiting clips 11 are provided inside the housing 1, and the curvature of the limiting clips 11 is adapted to the body of the vial 3 containing the medicine.

[0036] The front baffle 12 and the rear baffle 13 are respectively provided at the front end and the rear end of the vial 3;

[0037] The sealing film 2 completely covers the top surface of the housing 1.

[0038] This utility model provides a basically complete protective barrier through the shell 1. The vial 3 is limited by the limiting card 11, the front baffle 12, and the rear baffle 13. The sealing film 2 and the shell 1 are combined to form a closed cavity, which can protect the vial. The limiting card 11, the front baffle 12, and the rear baffle 13 can basically suppress the displacement of the vial 3 in all directions. Only when the tensile force on the vial 3 exceeds the clamping force of the limiting card 11 will it be dislodged.

[0039] To improve shock absorption, soft pads can be installed at the contact points between the limit card 11, the front baffle 12, and the rear baffle 13 and the vial 3.

[0040] Based on the above technical solution, the limiting card 11 includes two symmetrical claws 112 and a base 111. The bottom surface of the base 111 is connected to the bottom of the housing 1, and the top surface of the base 111 is an arc surface adapted to the bottle body.

[0041] The lower parts of the two claws 112 are smoothly connected to both ends of the base 111. The claws 112 and the base 111 are combined to stably hold the vial 3.

[0042] Based on the above technical solution, a protective atmosphere is filled between the sealing film 2 and the shell 1. The protective atmosphere has a single component, which can reduce pollution and maintain positive pressure between the shell 1 and the sealing film 2, thus playing a certain role in shock absorption.

[0043] Based on the above technical solution, the shell 1 is made of polyethylene or polypropylene, which gives the shell 1 a certain strength. The material itself is recyclable and can be recycled after use, making it more environmentally friendly.

[0044] Based on the above technical solution, the inner or outer surface of the shell 1 is provided with a light-shielding film, and the sealing film 2 contains an aluminum foil layer. The light-shielding film is opaque and plays a role in blocking light, which meets the conditions for drug preservation.

[0045] Based on the above technical solution, the housing 1 is equipped with an RFID tag, which records relevant information about the medicine.

[0046] As described above, this application can package vials containing targeted drugs, which improves the visual appeal and protective properties of the packaging, while also meeting the market demand for individual packaging.

[0047] Numerous specific details are set forth in this specification. However, it will be understood that embodiments of this invention may be practiced without these specific details. In some instances, well-known methods, structures, and techniques have not been shown in detail so as not to obscure the understanding of this specification. In the description of this specification, references to the terms "one embodiment," "some embodiments," "example," "specific example," or "some examples," etc., indicate that a specific feature, structure, material, or characteristic described in connection with that embodiment or example is included in at least one embodiment or example of this invention. In this specification, illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples. Furthermore, without contradiction, those skilled in the art can combine and integrate the different embodiments or examples described in this specification, as well as the features of the different embodiments or examples.

[0048] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of this utility model, and not to limit it. Although the utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features. Such modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of this utility model, and they should all be covered within the scope of the claims and specification of this utility model.

Claims

1. A medicine package, characterized by comprising: include: case; At least two limiting clips are provided inside the housing, and the curvature of the limiting clips is adapted to the body of the vial containing the medicine; A front baffle and a rear baffle are respectively located at the front end and the rear end of the vial; A sealing film completely covers the top surface of the housing.

2. The pharmaceutical package according to claim 1, wherein The limiting card includes two symmetrical claws and a base. The bottom surface of the base is connected to the bottom of the housing, and the top surface of the base is an arc surface adapted to the bottle body. The lower parts of the two claws are smoothly connected to both ends of the base.

3. The pharmaceutical package according to claim 1, wherein A protective atmosphere is filled between the sealing film and the shell.

4. The pharmaceutical package according to claim 1, wherein The shell is made of polyethylene or polypropylene.

5. The pharmaceutical pack according to claim 1 or 4, wherein The inner or outer surface of the housing is provided with a light-shielding film, and the sealing film includes an aluminum foil layer.

6. The pharmaceutical packaging box according to claim 1, wherein The housing contains an RFID tag.

Images